Literature DB >> 28755836

Influenza seasonality goes south in the Yucatan Peninsula: The case for a different influenza vaccine calendar in this Mexican region.

Guadalupe Ayora-Talavera1, Gerardo Montalvo-Zurbia Flores2, Jesus Gómez-Carballo3, Refugio González-Losa4, Laura Conde-Ferraez5, Marylin Puerto-Solís6, Irma López-Martínez7, Alberto Díaz-Quiñonez8, Gisela Barrera-Badillo9, Rodolfo Acuna-Soto10, Alicia A Livinski11, Wladimir J Alonso12.   

Abstract

INTRODUCTION: While vaccination may be relatively straightforward for regions with a well-defined winter season, the situation is quite different for tropical regions. Influenza activity in tropical regions might be out of phase with the dynamics predicted for their hemispheric group thereby impacting the effectiveness of the immunization campaign.
OBJECTIVE: To investigate how the climatic diversity of Mexico hinders its existing influenza immunization strategy and to suggest that the hemispheric vaccine recommendations be tailored to the regional level in order to optimize vaccine effectiveness.
METHODS: We studied the seasonality of influenza throughoutMexico by modeling virological and mortality data.De-trended time series of each Mexican state were analyzed by Fourier decomposition to describe the amplitude and timing of annual influenza epidemic cycles and to compare with each the timing of the WHO's Northern and Southern Hemispheric vaccination schedule.
FINDINGS: The timings of the primary (major) peaks of both virological and mortality data for most Mexican states are well aligned with the Northern Hemisphere winter (December-February) and vaccine schedule. However, influenza peaks in September in the three states of the Yucatan Peninsula. Influenza-related mortality also peaks in September in Quintana Roo and Yucatan whereas it peaks in May in Campeche. As the current timing of vaccination in Mexico is between October and November, more than half of the annual influenza cases have already occurred in the Yucatan Peninsula states by the time the Northern Hemispheric vaccine is delivered and administered.
CONCLUSION: The current Northern Hemispheric influenza calendar adopted for Mexico is not optimal for the Yucatan Peninsula states thereby likely reducing the effectiveness of the immunization of the population. We recommend that Mexico tailor its immunization strategy to better reflect its climatologic and epidemiological diversity and adopt the WHO Southern Hemisphere influenza vaccine and schedule for the Yucatan Peninsula.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Keywords:  Influenza; Mexico; Seasonality; WHO hemispheric influenza recommendation; Yucatan

Mesh:

Substances:

Year:  2017        PMID: 28755836     DOI: 10.1016/j.vaccine.2017.07.020

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Temporal distribution and genetic variants in influenza A(H1N1)pdm09 virus circulating in Mexico, seasons 2012 and 2013.

Authors:  Jose Reyes Canche-Pech; Laura Conde-Ferraez; Marylin Puerto-Solis; Refugio Gonzalez-Losa; Pilar Granja-Pérez; Salha Villanueva-Jorge; Maria Chan-Gasca; Jesus Gómez-Carballo; Luisa López-Ochoa; Bertha Jiménez-Delgadillo; Iram Rodríguez-Sánchez; Jorge Ramírez-Prado; Guadalupe Ayora-Talavera
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

2.  Authors' reply: Geographic resolution of surveillance data and influenza prevention in large countries.

Authors:  Saverio Caini; Wladimir J Alonso; Clotilde El-Guerche Séblain; François Schellevis; John Paget
Journal:  Euro Surveill       Date:  2017-10

Review 3.  Fogarty International Center collaborative networks in infectious disease modeling: Lessons learnt in research and capacity building.

Authors:  Martha I Nelson; James O Lloyd-Smith; Lone Simonsen; Andrew Rambaut; Edward C Holmes; Gerardo Chowell; Mark A Miller; David J Spiro; Bryan Grenfell; Cécile Viboud
Journal:  Epidemics       Date:  2018-10-23       Impact factor: 4.396

4.  Influenza in Yucatan in 2018: Chronology, characteristics and outcomes of ambulatory and hospitalized patients.

Authors:  Nina I Mendez-Dominguez; Luis O Bobadilla-Rosado; Lizbeth S Fajardo-Ruiz; Andrea Camara-Salazar; Salvador Gomez-Carro
Journal:  Braz J Infect Dis       Date:  2019-09-25       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.